Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2007 / Cilt: 17 - Sayı: 1

Major histocompatibility complex (MHC) II deficiency needs early stem cell transplantation: A case report

MHC II Ekkspresyon defekti erken kök hücre nakli gerektirir:Bir olgu sunumu

Pages
51–55
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

He died because of sepsis and multi-organ failure as stem cell transplantation could not be performed immediately after diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Major histocompatibility complex (MHC) II deficiency is a rare primary immunodeficiency disorder characterized by defects in human leukocyte antigen class II expression and lack of cellular and humoral immune responses to foreign antigens.
📊
Key Findings & Data:Clinical onset occurs early in life with recurrent infections and chronic diarrhea.
💡
Conclusion & Impact:He died because of sepsis and multi-organ failure as stem cell transplantation could not be performed immediately after diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Erkek · Genler · MHC sınıf II

Abstract

Major histocompatibility complex (MHC) II deficiency is a rare primary immunodeficiency disorder characterized by defects in human leukocyte antigen class II expression and lack of cellular and humoral immune responses to foreign antigens. Clinical onset occurs early in life with recurrent infections and chronic diarrhea. The prognosis is poor and only curative treatment is stem cell transplantaiion (SCT) performed early in life. In this report, we present a patient who had immune deficiency caused by MHC Class II expression defect. He died because of sepsis and multi-organ failure as stem cell transplantation could not be performed immediately after diagnosis.

Özet

Major histokompatibilite kompleks (MHC) II eksikliği insan lökosit antijenlerinden sınıf II ekspresyon defekti ile karakterize, nadir görülen bir primer immun yetmezliktir. Hastalıkta hem sellüler hem de humoral immun yanıt eksikliği olması nedeniyle yaşamın erken döneminde tekrarlayan enfeksiyonlar ve kronik diyare görülür. Prognozu kötü olan bu hastalıkta kok hücre nakli (KHN) tek kiiratif tedauidir. Bu yazıda HLA uygun donörü olmayan ve alternatif donörden yapılacak nakil için ailenin onay vermediği, sepsis ve multiorgan yetmezliği ile kaybedilmiş MHC Class II ekspresyon defekti olan bir olgu sunulmuştur.

🔖

Cite This Article

YENİAY, B. S., KARACA, N. E., ÖZTÜRK, C., AKSU, G., KÜTÜKÇÜLER, N. (2007). Major histocompatibility complex (MHC) II deficiency needs early stem cell transplantation: A case report. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 17 - Sayı: 1, 51–55. https://ajindex.com/articles/268645

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Glirnscher LH, Kara CJ. Sequences and factors: a guide to MHC class II transcription. Annu Rev Immunol 1992;10:13-49
  2. Goust JM. Medical Immunology. In: Virella G. (ed) Major Histocompatibilty Complex (50th ed) New York: Marcel Dekker Press 2001:31-51
  3. Lisowska-Grospierre B, Charron D J, de Pre'val C ve ark. A defect in the regulation of major histocom-patibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with a combined immunodeficiency syndrome. J Clin Invest 1985:76:381
  4. Boss J M. Regulation of transcription of MHC class 11 genes. Current Opinion in Immunology 1997;9: 107-13
  5. Steimle V, Otten LA, Zufferey M, Manch B. Comp-lementation cloning of an MHC Class II trans- activator mutated in hereditary MHC class II defi-ciency (or bare lymphocyte syndrome). Cell 1993; 75:135-46
  6. Hermann MW, Vojtech T, Heinz G, Sonja L ve ark. Residual expression of functional MHC class II mole-cules in twin brothers with MHC class II deficiency is cell type specific. British Journal of Haematology 2001;115:460-71
  7. Virella G, Sleasman J. Medical Immunology. In: Virella G. (ed). Primary Immunodeficiency Diseases (50th ed) New York: Marcel Deldter Pres. 2001:573-599
  8. Wiszniewski W, Fondaneche M, Deist F ve ark. Mutation in the Class II trans-Activator Leading to a Mild Immunodeficiency The Journal of Immunology 2001:167:1787-94
  9. Klein C, Lisowska-Grospierre B, LeDeist F ve ark. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 1993;123:921-9
  10. Klein C. Cavazzana-Calvo M, Deist F ve ark. Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients. Blood 1995;85:2:580-7.